PHRM:CC News and Press, Pharmather Holdings Ltd. From 03/23/22

100% of patients treated with ketamine demonstrated reduction in dyskinesias as measured by the Unified Dyskinesia Rating Scale Ketamine was well tolerated with no serious adverse events reported Study results are adequate to give an effect size in powering a Phase 3 cli...